{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:58:58Z","timestamp":1776272338972,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-026-00482-2","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:13:26Z","timestamp":1776269606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disease burden of ATTR amyloidosis based on the SF-36\u00ae health survey"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6307-2445","authenticated-orcid":false,"given":"Vaishali","family":"Sanchorawala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Greatsinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Staron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Berk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Mendelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"J. Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Tabatabaeepour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jess","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Signorovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"482_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1001\/jama.2024.0442","volume":"331","author":"FL Ruberg","year":"2024","unstructured":"Ruberg FL, Maurer MS. Cardiac Amyloidosis Due to Transthyretin Protein: A Review. JAMA. 2024;331:778\u201391.","journal-title":"JAMA"},{"key":"482_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cardfail.2019.08.001","volume":"25","author":"S Dorbala","year":"2019","unstructured":"Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. \/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. J Card Fail. 2019;25:e1\u201339. ASNC\/AHA\/ASE\/EANM\/HFSA.","journal-title":"J Card Fail"},{"key":"482_CR3","unstructured":"36-Item Short Form Survey from the RAND Medical Outcomes Study. https:\/\/www.rand.org\/health-care\/surveys_tools\/mos\/36-item-short-form.html. Accessed 8 Jul 2025."},{"key":"482_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13023-016-0564-2","volume":"12","author":"M Bayliss","year":"2017","unstructured":"Bayliss M, McCausland KL, Guthrie SD, White MK. The burden of amyloid light chain amyloidosis on health-related quality of life. Orphanet J Rare Dis. 2017;12:15.","journal-title":"Orphanet J Rare Dis"},{"key":"482_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/PROM.S146849","volume":"8","author":"MK White","year":"2017","unstructured":"White MK, McCausland KL, Sanchorawala V, Guthrie SD, Bayliss MS. Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samples. Patient Relat Outcome Meas. 2017;8:157\u201367.","journal-title":"Patient Relat Outcome Meas"},{"key":"482_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/PROM.S399658","volume":"14","author":"AA Rizio","year":"2023","unstructured":"Rizio AA, White MK, D\u2019Souza A, Hsu K, Schmitt P, Quock TP, et al. Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group. Patient Relat Outcome Meas. 2023;14:153\u201369.","journal-title":"Patient Relat Outcome Meas"},{"key":"482_CR7","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1001\/jama.2013.283815","volume":"310","author":"JL Berk","year":"2013","unstructured":"Berk JL, Suhr OB, Obici L, et al. Repurposing diflunisal for familial amyloid polyneuropathy: A randomized clinical trial. JAMA. 2013;310:2658\u201367.","journal-title":"JAMA"},{"key":"482_CR8","unstructured":"Ware J, MA K, Keller SD. SF-36 Physical and Mental Health Summary Scales: a User\u2019s Manual. 1993;8:23\u20138."},{"key":"482_CR9","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jchf.2023.10.003","volume":"12","author":"KP Shah","year":"2024","unstructured":"Shah KP, Khan SS, Baldridge AS, Grady KL, Cella D, Goyal P, et al. Health Status in Heart Failure and Cancer: Analysis of the Medicare Health Outcomes Survey 2016\u20132020. JACC Heart Fail. 2024;12:1166\u201378.","journal-title":"JACC Heart Fail"},{"key":"482_CR10","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1001\/jama.2024.2868","volume":"331","author":"MS Maurer","year":"2024","unstructured":"Maurer MS, Miller EJ, Ruberg FL. Addressing Health Disparities-The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger. JAMA. 2024;331:1809\u201311.","journal-title":"JAMA"},{"key":"482_CR11","doi-asserted-by":"publisher","first-page":"1124660","DOI":"10.3389\/fcvm.2023.1124660","volume":"10","author":"M Kharoubi","year":"2023","unstructured":"Kharoubi M, B\u00e9zard M, Broussier A, Galat A, Gounot R, Poullot E, et al. Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis. Front Cardiovasc Med. 2023;10:1124660.","journal-title":"Front Cardiovasc Med"},{"key":"482_CR12","first-page":"52","volume":"31","author":"A Aimo","year":"2024","unstructured":"Aimo A, Teresi L, Castiglione V, Picerni AL, Niccolai M, Severino S, et al. Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis. 2024;31:52\u201361.","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"482_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/PROM.S411721","volume":"14","author":"M O\u2019Connor","year":"2023","unstructured":"O\u2019Connor M, Hsu K, Broderick L, McCausland KL, LaGasse K, Rebello S, et al. The Transthyretin Amyloidosis - Quality of Life (ATTR-QOL) Questionnaire: Development of a Conceptual Model and Disease-Specific Patient-Reported Outcome Measure. Patient Relat Outcome Meas. 2023;14:213\u201322.","journal-title":"Patient Relat Outcome Meas"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00482-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00482-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00482-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:13:27Z","timestamp":1776269607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-026-00482-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1186\/s40959-026-00482-2","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board (IRB) approval was obtained, and all patients provided informed consent for the use of clinical data in research in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}